跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRZ-ATORVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRZ-ATORVASTATIN
Authorized
STANDARD
PRZ-ATORVASTATIN
pharmaris canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
612cce49276d8fea
Company
pharmaris canada inc
Type
Standard
Approval Details
Approval Id
612cce49276d8fea
Drug Approval Canada Name
PRZ-ATORVASTATIN
Product Name
PRZ-ATORVASTATIN
Status
Marketed
Status Date
2022-09-19
Original Market Date
2022-09-19
Din
02521555
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA05 ATORVASTATIN
Atc Name
c 10 aa 05
Aig Number
0133055001
Company Name
pharmaris canada inc
Company Address
102, 8310 130th Street, Surrey, British Columbia, Canada, V3W 8J9
Active Ingredients
ATORVASTATIN (ATORVASTATIN CALCIUM)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
612cce49276d8fea
Type
Standard
Back to Health Canada Approvals